Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sm14 Vaccine Schedule in Schistosomiasis
NCT05658614Phase 2Unknown
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Jul 2022
- Primary completion
- Sep 2023
- Modality
- Split/Subunit Vaccines, Peptide-based Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Sm14 in schistosomiasis mansoni, schistosomiasis haematobium, sponsored by Fundação Oswaldo Cruz. Status: unknown.
02
Drugs
Sm14
03
Conditions
schistosomiasis mansonischistosomiasis haematobium
Beyond the preview
Go deeper on NCT05658614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05658614.